Pregnant women and infants are at risk should they contract mpox but there are no approved vaccines for this population.

The registrational trial is expected to support the approval for Bavarian’s mpox/smallpox vaccine use in children between two ...

To safeguard against additional cases, either at home or while deployed, the Defense Health Agency and the services have made ...

While the vaccine was originally free during the 2022 outbreak, on April 1, Bavarian Nordic A/S, the vaccine manufacturer, ...

Oct 14 (Reuters) - The World Health Organization said on Monday it had approved Bavarian Nordic's (BAVA.CO), opens new tab mpox vaccine for adolescents aged 12 to 17 years, an age group considered ...

A clinical trial by the US National Institutes of Health (NIH) has shown that Bavarian Nordic’s mpox vaccine induced an antibody response in adolescents equivalent to that of adults. The interim ...

An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current ...

A new scientific trial evaluating Bavarian Nordic’s mpox vaccine in pregnant and breastfeeding women and infants is set to launch in the Democratic Republic of Congo (DRC). This research could expand ...

An initial 899,000 vaccine doses have been allocated for nine countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organizations say.

Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine September 24, 2024 Future of Healthcategory Bavarian says mpox vaccine approved by EU regulator for adolescents ...

The U.S. Food and Drug Administration has also approved Bavarian's shot, but only for use in adults 18 years and older, although it granted Emergency Use Authorization for its use in adolescents ...

In September, after facing criticism on moving too slowly on vaccines, the World Health Organization cleared Bavarian ...